DISPERSOL TECHNOLOGIES, LLC

Profile

Company Names

DISPERSOL TECHNOLOGIES, LLC

Addresses

111 W. COOPERATIVE WAY, BLDG. 3, STE. 300, GEORGETOWN, TX 78626

111 W. COOPERATIVE WAY, BUILDING 2, SUITE 200, GEORGETOWN, TX 78626

9442 N. CAPITAL OF TEXAS, AUSTIN, TX 78759

Phone Numbers

(512) 686-4740
512-686-4740
254-743-6421

 

Entity Type:

LIMITED LIABILITY COMPANY

Industry:

PHARMACEUTICALS

Year Incorporated:

2007

State Incorporated:

TEXAS

Total Amount Raised:

$37,636,494.00

Number of Funding Rounds:

7
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
7
2020-10-05 
$4,690,836.00 
$5,000,004.00 
$309,168.00 
Equity 
6
2018-01-11 
$16,028,748.00 
$27,317,592.00 
$11,288,844.00 
Equity 
5
2016-01-20 
$12,000,000.00 
$12,000,000.00 
$0.00 
Equity 
4
2014-02-24 
$3,021,690.00 
$7,521,690.00 
$4,500,000.00 
Equity 
3
2013-05-14 
$611,834.00 
$1,000,000.00 
$388,166.00 
Debt 
2
2012-01-24 
$641,693.00 
$1,500,000.00 
$858,307.00 
Equity 
1
2012-01-20 
$641,693.00 
$1,500,000.00 
$858,307.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
CHRIS 
 
BROUGH 
DIRECTOR
EDWARD 
 
HOBART 
EXECUTIVE OFFICER, DIRECTOR
EDWARD 
R. 
HOBART 
EXECUTIVE OFFICER, DIRECTOR
SHAUN 
 
KIRKPATRICK 
EXECUTIVE OFFICER, DIRECTOR
JAMES 
 
MACK 
DIRECTOR
EDWARD 
M. 
RUDNIC, PH.D. 
EXECUTIVE OFFICER, DIRECTOR
JEFFREY 
D. 
SAMBERG 
DIRECTOR
GERSHON 
 
YANIV 
EXECUTIVE OFFICER, DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2020-10-05 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-01-11 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2016-01-20 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2014-02-24 
D/A
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2013-05-14 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2013-05-14 
D/A
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2012-01-24 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2012-01-20 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#